Quince Therapeutics, Inc. (QNCX) — Cash Flow Quality Index

Latest as of March 2026: -0.21x

Quince Therapeutics, Inc. (QNCX) has a Cash Flow Quality Index of -0.21x as of March 2026. Operating cash flow of $-7.63 Million is below net income of $35.91 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore QNCX operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.

Cash Flow Quality Index

-0.21x

Operating CF / Net Income

Operating Cash Flow

$-7.63 Million

USD

Net Income

$35.91 Million

USD

Data as of

Mar 2026

Most recent filing

Annual Cash Flow Quality Index for Quince Therapeutics, Inc. (None–None)

Year-by-year earnings quality comparison for Quince Therapeutics, Inc..

Year	Quality Index	Operating CF (USD)	Net Income	YoY Change

Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.